The AWARD-PEDS research study will assess an investigational drug for its effectiveness in the treatment of type 2 diabetes in adolescents.
The rate of type 2 diabetes in adolescents continues to rise. Currently, metformin is the only oral drug recommended as the initial medical treatment for type 2 diabetes in adolescents; however, metformin is not suitable for all adolescents. Hence, there is a need for more treatment options for adolescents with type 2 diabetes.
About the StudyParticipation in this research study can help examine the investigational drug's effectiveness in an adolescent population. Pennington Biomedical is seeking volunteers 10 to 17 years of age, who have a Body Mass Index (BMI) greater than or equal to the 85th percentile for age and gender – and who have been diagnosed with type 2 diabetes – to participate in this study.
- 1 screening visit
- 7 visits to the Pennington Biomedical clinic
- 9 telephone calls
- Health measurements (blood pressure, pulse, height, weight, etc.)
- Physical examination
- ECG test to determine heart health
- Blood and urine tests
Number of Visits:
- Be 10 to 17 years old
- Be diagnosed with type 2 diabetes
- Have a body mass index in the 85th percentile calculate your BMI
- Not be pregnant
To qualify for the AWARD-PEDS research study, participants should:
Study DurationParticipation in this research study will last approximately 1 year and 2 months.
CompensationCompensation of up to $440 is offered for completion of this study.
To see if your 10-17 year old qualifies for this research study, a parent or guardian must complete the online screening form below. You may also call 225-763-3000 or email email@example.com.
If you think you may be eligible, please click the button below to screen online.GET STARTED
Please do not fill out this questionnaire for anyone other than yourself unless you are their legal guardian.
If you know someone who may be interested please direct them to the site or have them call us directly at 225-763-3000.